跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
V-01
首页
药物
V-01
V-01
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
TRANSGENIC RABBIT WITH COMMON LIGHT CHAIN
EP 3367786 A1
申请人: HOFFMANN LA ROCHE
优先权: 2015
CN
EP
4 件公开
HUMAN T CELL RECEPTORS TARGETING TUMOR-ENHANCED SPLICING EPITOPES ON HLA-A*02:01 FOR SMALL CELL CARCINOMA
EP 4695284 A1
申请人: THE REGENTS OF UNIV OF CALIFORNIA
优先权: 2023
EP
WO
2 件公开
Quinoline derivatives for use as intermediates in the synthesis of heterocyclylalcoyl piperidines
EP 1695964 A1
申请人: NOVEXEL
优先权: 2001
EP
SUBSTITUTED ORGANOPOLYSILOXANES AND USE THEREOF
US 2009062234 A1
申请人: PHOSPHONICS LTD
优先权: 2004
US
D-type amino acid modified TMTP1 polypeptide ligand radioactive probe as well as preparation method and application thereof
CN 117164664 A
申请人: THE FIRST AFFILIATED HOSPITAL OF XIAMEN UNIV XIAMEN FIRST HOSPITAL XIAMEN RED CROSS HOSPITAL XIAMEN
优先权: 2023
CN
PHARMACEUTICALLY ACCEPTABLE SALT OF PSD-95 POLYPEPTIDE INHIBITOR AND PREPARATION METHOD THEREFOR
WO 2026012336 A1
申请人: FUJIAN SHENGDI PHARMACEUTICAL CO LTD
优先权: 2024
WO
药物
反馈